A broad range of clinical biomarkers, such as total leukocyte levels, lymphocyte and neutrophil measurements, along with inflammatory markers like CRP, PCT, and IL-6, have been thoroughly explored in prior research and linked to both the progression and fatal outcomes of COVID-19 [39]. The gene discussed is IL6; the disease is COVID-19.